Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers
- PMID: 11265923
- DOI: 10.1097/00004703-200102000-00008
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers
Abstract
In 1992, the National Institute of Mental Health and 6 teams of investigators began a multisite clinical trial, the Multimodal Treatment of Attention-Deficit Hyperactivity Disorder (MTA) study. Five hundred seventy-nine children were randomly assigned to either routine community care (CC) or one of three study-delivered treatments, all lasting 14 months. The three MTA treatments-monthly medication management (usually methylphenidate) following weekly titration (MedMgt), intensive behavioral treatment (Beh), and the combination (Comb)-were designed to reflect known best practices within each treatment approach. Children were assessed at four time points in multiple outcome. Results indicated that Comb and MedMgt interventions were substantially superior to Beh and CC interventions for attention-deficit hyperactivity disorder symptoms. For other functioning domains (social skills, academics, parent-child relations, oppositional behavior, anxiety/depression), results suggested slight advantages of Comb over single treatments (MedMgt, Beh) and community care. High quality medication treatment characterized by careful yet adequate dosing, three times daily methylphenidate administration, monthly follow-up visits, and communication with schools conveyed substantial benefits to those children that received it. In contrast to the overall study findings that showed the largest benefits for high quality medication management (regardless of whether given in the MedMgt or Comb group), secondary analyses revealed that Comb had a significant incremental effect over MedMgt (with a small effect size for this comparison) when categorical indicators of excellent response and when composite outcome measures were used. In addition, children with parent-defined comorbid anxiety disorders, particularly those with overlapping disruptive disorder comorbidities, showed preferential benefits to the Beh and Comb interventions. Parental attitudes and disciplinary practices appeared to mediate improved response to the Beh and Comb interventions.
Similar articles
-
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder.Pediatrics. 2004 Apr;113(4):754-61. doi: 10.1542/peds.113.4.754. Pediatrics. 2004. PMID: 15060224 Clinical Trial.
-
A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.Arch Gen Psychiatry. 1999 Dec;56(12):1073-86. doi: 10.1001/archpsyc.56.12.1073. Arch Gen Psychiatry. 1999. PMID: 10591283 Clinical Trial.
-
Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder.Arch Gen Psychiatry. 1999 Dec;56(12):1088-96. doi: 10.1001/archpsyc.56.12.1088. Arch Gen Psychiatry. 1999. PMID: 10591284 Clinical Trial.
-
In the wake of the MTA: charting a new course for the study and treatment of children with attention-deficit hyperactivity disorder.Can J Psychiatry. 1999 Dec;44(10):999-1006. doi: 10.1177/070674379904401006. Can J Psychiatry. 1999. PMID: 10637679 Review.
-
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details.J Atten Disord. 2008 Jul;12(1):15-43. doi: 10.1177/1087054708319525. J Atten Disord. 2008. PMID: 18573924
Cited by
-
School-based Screening to Identify Children At Risk for Attention-Deficit/Hyperactivity Disorder: Barriers and Implications.Child Health Care. 2016;45(3):241-265. doi: 10.1080/02739615.2014.948160. Epub 2015 Sep 18. Child Health Care. 2016. PMID: 27642209 Free PMC article.
-
Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.J Child Adolesc Psychopharmacol. 2013 Nov;23(9):597-604. doi: 10.1089/cap.2012.0085. Epub 2013 May 9. J Child Adolesc Psychopharmacol. 2013. PMID: 23659360 Free PMC article. Clinical Trial.
-
Methodology for conducting the children's attention-deficit hyperactivity disorder telemental health treatment study in multiple underserved communities.Clin Trials. 2013;10(6):949-58. doi: 10.1177/1740774513494880. Epub 2013 Jul 29. Clin Trials. 2013. PMID: 23897950 Free PMC article. Clinical Trial.
-
New developments in the treatment of attention-deficit/hyperactivity disorder in primary care.Prim Care Companion J Clin Psychiatry. 2006;8(4):224-33. Prim Care Companion J Clin Psychiatry. 2006. PMID: 16964318 Free PMC article. No abstract available.
-
Psychometric properties of the quality of life scale Child Health and Illness Profile-Child Edition in a combined analysis of five atomoxetine trials.Atten Defic Hyperact Disord. 2011 Dec;3(4):335-49. doi: 10.1007/s12402-011-0066-y. Epub 2011 Oct 11. Atten Defic Hyperact Disord. 2011. PMID: 21986814 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical